AUG 25, 2018 4:55 PM PDT

Gene Therapy for Eye Disease is Getting Closer to the Clinic

WRITTEN BY: Carmen Leitch

An inherited eye disease called retinitis pigmentosa (RP) impacts roughly one of every 3,500 Americans; it disrupts the cells in the retina, which is a vital, light-sensitive lining in the eye. Peripheral and nighttime vision suffers when it begins to break down. Researchers at University of Florida Health and Penn Medicine have now developed a way to treat this devastating disorder with gene therapy. Reporting in the Proceedings of the National Academy of Sciences, the team successfully improved eyesight in animals that were afflicted with RP.

"We've known for decades that this specific molecule causes a specific form of retinitis pigmentosa, but developing a treatment has not been straightforward," explained co-lead author Dr. Artur V. Cideciyan, research professor of ophthalmology at Penn Medicine. "Now, with these elegant results based on years of study in dogs, we can start working toward treating these mutations and prevent deterioration of photoreceptor cells in humans."

In this work, a tool called an adeno-associated virus, or AAV, was used to deliver the gene therapy, which in this case replaces a mutant copy of the rhodopsin gene with a normal copy, thereby saving photoreceptor cells (as explained in the video). The virus has been demonstrated as safe in a rodent model and in humans in previous studies.

"We were able to save cone vision in the dogs," said Dr. Alfred Lewin, a professor in the UF College of Medicine's department of molecular genetics and microbiology and a member of the UF Genetics Institute. "If we can do that in people, it will save the central vision that allows them to recognize faces, read and watch television."

After UF Health scientists created the therapeutic, scientists at Penn treated ten beagles with RP. After nine weeks, mutant gene levels had been significantly reduced in areas of the eye that had been treated. After eight months, other photoreceptor cells - rods - in the retina were also protected.

"It's a one treatment fits all," noted co-lead author William A. Beltran, a professor of ophthalmology at Penn's School of Veterinary Medicine. "The treatment targets a region of the rhodopsin gene that is homologous in humans and dogs and is separate from where the mutations are located. That gives us great hope about making this a translational treatment."

Lewis is hopeful that this technology can be extrapolated to treat other genetic mutations that cause blindness, and maybe even single gene mutations that impact other organs like the kidney and liver.

For now, this work will continue so that the exact dosage can be refined.


Sources: University of Florida, PNAS

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAY 08, 2022
Genetics & Genomics
Genetic Inversions Seem to be More Common Than We Knew
MAY 08, 2022
Genetic Inversions Seem to be More Common Than We Knew
While most of us tend to carry the same general set of genes, within the billions of bases that make up the human genome ...
MAY 13, 2022
Drug Discovery & Development
Multiple Mental Health Diagnoses are Increasingly Common. Why?
MAY 13, 2022
Multiple Mental Health Diagnoses are Increasingly Common. Why?
Mental illness has become increasingly common. The number of people with anxiety and depression, specifically, has stead ...
JUL 07, 2022
Neuroscience
Observing Gene Expression in Real-Time in Live Mouse Brains
JUL 07, 2022
Observing Gene Expression in Real-Time in Live Mouse Brains
Scientists still have a lot to learn about how memories are created and stored in the brain. The expression of genes lea ...
JUL 14, 2022
Clinical & Molecular DX
A magnetic bead for every need: Expanding applications with conjugated magnetic beads
JUL 14, 2022
A magnetic bead for every need: Expanding applications with conjugated magnetic beads
Magnetic beads (or superparamagnetic particles) can be used for the isolation and purification of cells, nucleic acids, ...
JUL 31, 2022
Genetics & Genomics
A Brief History of Human Gene Editing
JUL 31, 2022
A Brief History of Human Gene Editing
DNA was characterized in 1953, and shortly after, the nature of the genetic code was revealed.
AUG 14, 2022
Immunology
After Transplant, Another Person is Cured of HIV
AUG 14, 2022
After Transplant, Another Person is Cured of HIV
For the second time this year and only the fourth time ever, researchers have announced that a person has been cured of ...
Loading Comments...